Literature DB >> 3934276

Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.

R E Schifferle, H J Jennings, M R Wessels, E Katzenellenbogen, R Roy, D L Kasper.   

Abstract

The types Ia and Ib group B streptococcal type-specific polysaccharides have remarkable immunologic differences despite a great deal of structural similarity. Although these two complex polysaccharides differ only by a single glycosidic linkage, they are antigenically distinct. Furthermore, terminal sialic acid residues appear to be critical to the immunodeterminant on the type Ia polysaccharide, whereas the antigenicity of the type Ib polysaccharide does not show this dependence on sialic acid. In the current investigation we defined better the immunodeterminant of these polysaccharides. With homologous rabbit antiserum, the type Ia native and core polysaccharides demonstrated partial serologic identity, whereas the type Ib native and core polysaccharides demonstrated complete serologic identity. Surprisingly, the type I degalactosylated polysaccharide, degraded structure, was capable of reacting with a population of antibodies present in type Ia antiserum similar to the complete type Ia native polysaccharide, although demonstrating a reduced level of immunodeterminant expression. Unlike the reactions of the type Ia polysaccharides with homologous rabbit antiserum, the Ib native and core polysaccharides were able to react with identical populations of antibodies in type Ib-specific antiserum. A minor population of antibodies was demonstrated in the type Ib antiserum, which was reactive with the degalactosylated polysaccharide. That a population of antibodies reactive toward the degalactosylated polysaccharide is present in both type Ia and type Ib antisera suggests that the Iabc cross-reacting determinant is due to the presence of serum antibodies reactive with this trisaccharide repeating unit, which is shared by both the type Ia and the type Ib native and core polysaccharides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934276

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  The lipooligosaccharides of Haemophilus ducreyi are highly sialylated.

Authors:  W Melaugh; A A Campagnari; B W Gibson
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

2.  Murine monoclonal antibodies to type Ib polysaccharide of group B streptococci bind to human milk oligosaccharides.

Authors:  D G Pritchard; B M Gray; M L Egan
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  M R Wessels; L C Paoletti; A K Rodewald; F Michon; J DiFabio; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

4.  A model of high-affinity antibody binding to type III group B Streptococcus capsular polysaccharide.

Authors:  M R Wessels; A Muñoz; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.

Authors:  M R Wessels; W J Benedí; H J Jennings; F Michon; J L DiFabio; D L Kasper
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

6.  Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching.

Authors:  Hilde-Kari Guttormsen; Lawrence C Paoletti; Keith G Mansfield; Wojcieck Jachymek; Harold J Jennings; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

7.  Regioselective Glycosylation Strategies for the Synthesis of Group Ia and Ib Streptococcus Related Glycans Enable Elucidating Unique Conformations of the Capsular Polysaccharides.

Authors:  Linda Del Bino; Ilaria Calloni; Davide Oldrini; Maria Michelina Raso; Rossella Cuffaro; Ana Ardá; Jeroen D C Codée; Jesús Jiménez-Barbero; Roberto Adamo
Journal:  Chemistry       Date:  2019-11-04       Impact factor: 5.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.